The role of intestinal microbiota in the pathogenesis of sarcopenic non-alcoholic fatty liver disease
HERALD of North-Western State Medical University named after I.I. Mechnikov · 26.12.2025 · 17 (4) · 5-12
DOI: 10.17816/mechnikov636470 ↗Kurz gefasst
Fachartikel in der Zeitschrift HERALD of North-Western State Medical University named after I.I. Mechnikov, online erschienen am 26.12.2025. Verfasst von Mikhail E. Statsenko und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
The global incidence of non-alcoholic fatty liver disease is increasing worldwide, necessating targeted research at both the population and individual levels. Another global health concern is the rising number of patients with sarcopenia. The association between these two diseases, leading to disability, poor prognosis, and increased mortality, is driven by complex interplay mechanisms involving the intestinal microbiota and the formation of the gut–liver and gut–muscle pathogenetic axes. This scientific review aims to identify the causal relationship between intestinal microbiota dysbiosis and the development of sarcopenic non-alcoholic fatty liver disease. Contemporary studies of the intestinal microbiota in patients with sarcopenic non-alcoholic fatty liver disease, conducted at the level of nucleotide sequences of microbial genomic DNA and mitochondrial RNA, have revealed intestinal microbiota dysbiosis as well as increased permeability of the mucosal-epithelial barrier, accompanied by microbial translocation, activation of low-grade inflammatory responses, triggering of pro-inflammatory cytokine production, and the development of metabolic and structural changes in the liver and muscles. This provides the fundamental basis for the formation of bidirectional pathogenetic connections between the intestinal microbiota, liver, and muscles along the gut–liver–muscle axis. Further study of the role of the intestinal microbiota in the development and progression of non-alcoholic fatty liver disease in association with sarcopenia will help to develop a strategy for pathogenetically-based treatment and prevention of these comorbid conditions.
Zitieren
APA
Statsenko, M. E., Myazin, R. G., Razvalyaeva, O. V., & Sergeev, V. S. (2025). The role of intestinal microbiota in the pathogenesis of sarcopenic non-alcoholic fatty liver disease. HERALD of North-Western State Medical University named after I.I. Mechnikov, 17(4), 5-12. https://doi.org/10.17816/mechnikov636470
Vancouver
Statsenko ME, Myazin RG, Razvalyaeva OV, Sergeev VS. The role of intestinal microbiota in the pathogenesis of sarcopenic non-alcoholic fatty liver disease. HERALD of North-Western State Medical University named after I.I. Mechnikov. 2025;17(4):5-12. doi:10.17816/mechnikov636470
BibTeX
@article{Statsenko2025,
author = {Statsenko, Mikhail E. and Myazin, Roman G. and Razvalyaeva, Olga V. and Sergeev, Vladimir S.},
title = {The role of intestinal microbiota in the pathogenesis of sarcopenic non-alcoholic fatty liver disease},
journal = {HERALD of North-Western State Medical University named after I.I. Mechnikov},
year = {2025},
volume = {17},
number = {4},
pages = {5--12},
doi = {10.17816/mechnikov636470}
}
EUVIMED